Trial
NCT02998541
Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Shire
Collaborators
—
Condition
Adenoviral Conjunctivitis
Intervention
SHP640
Why stopped
Sponsor decision, unrelated to safety
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-06-14